Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective ...

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

Pancreatic cancer is one of the most lethal malignancies, with nearly 50,000 deaths annually in the United States, according ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Pancreatic Cancer.

The article continued: Additionally, the oncology sector has attracted significant investment, with companies like Ottimo Pharma raising $140 million to develop more effective cancer treatments with ...